Trial | NCT00447889  Report issue

Title

A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography
A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR)

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    None
This is a clinical study of gadoteric acid in non-coronary MR angiography.
Study Started
Mar 31
2006
Primary Completion
Nov 30
2007
Study Completion
Nov 30
2007
Last Update
Nov 26
2008
Estimate

Drug gadoteric acid

Criteria 

Inclusion Criteria:

Male or female, at least the age of legal maturity
Strongly suspected of having non-coronary arterial disease, detected clinically
Scheduled to undergo x-ray angiography examination
Female patients must be using effective contraception or be surgically sterilized or post-menopausal.
Females of childbearing potential must have a documented negative urine pregnancy test.

Exclusion Criteria:

Contraindication to magnetic resonance imaging (MRI)
Any metallic medical device in the vascular territory for which the patient is to undergo imaging examinations
Congenital morphologic vascular abnormalities
Known allergy to gadolinium chelates
Pregnant, breast feeding, or planning to become pregnant during the trial
Received a gadolinium complex within 2 days or iron oxide nanoparticles within 7 days before the gadoteric acid-enhanced magnetic resonance angiography (MRA) examination.
No Results Posted